Home - Orbsen Therapeutics

In the News Product Pipeline We are working on the development of an extensive range of therapies based on our proprietary technologies. The targets for these therapies include Diabetic Foot Ulcers Acute Respiratory Distress Syndrome - ARDS Diabetic Kidney Disease - DKD

OVERVIEW

This domain orbsentherapeutics.com presently has a traffic ranking of zero (the smaller the more traffic). We have scanned one page within the website orbsentherapeutics.com and found six websites referring to orbsentherapeutics.com. We have noted three contacts and locations for orbsentherapeutics.com to help you communicate with them. We have noted three public communication platforms owned by orbsentherapeutics.com. This domain orbsentherapeutics.com has been online for seven hundred and four weeks, one hour, nineteen minutes, and nine seconds.
Pages Crawled
1
Links to this site
6
Contacts
3
Locations
3
Social Links
3
Online Since
Apr 2011

ORBSENTHERAPEUTICS.COM RANKINGS

This domain orbsentherapeutics.com is seeing diverging quantities of traffic all over the year.
Traffic for orbsentherapeutics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for orbsentherapeutics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for orbsentherapeutics.com

Date Range

All time
This Year
Last Year
Last Month

ORBSENTHERAPEUTICS.COM HISTORY

This domain orbsentherapeutics.com was first recorded on April 28, 2011. It was updated on the date of April 28, 2014. This domain will expire on the date of April 28, 2015. As of today, it is seven hundred and four weeks, one hour, nineteen minutes, and nine seconds old.
REGISTERED
April
2011
UPDATED
April
2014
EXPIRED
April
2015

WEBSITE LENGTH OF LIFE

13
YEARS
5
MONTHS
28
DAYS

LINKS TO WEB SITE

Ignite Technology Transfer Office, National University of Ireland, Galway NUI Galway

Guiding Breakthrough Research at NUI Galway towards Business Reality. Our services assist in the knowledge transfer process for Industry and Investors as well as informing the Research Community at NUI Galway on matters of policy and process. Subscribe to our mailing list.

VISICORT Improving Immune System Response to Corneal Transplants

Improving the Success Rate of Corneal Transplants. Corneal disease is a leading cause of blindness worldwide and affects individuals of both genders and of all age groups. THERE ARE OVER 100,000. VISICORT WILL PROFILE DATA FROM 700 CORNEAL TRANSPLANT RECIPIENTS. TO ULTIMATELY IMPROVE CORNEAL TRANSPLANT SUCCESS. VISICORT partners involved in exciting new stem cell project.

MERLIN Developing Stem Cell-based Therapies

Project Materials, Photos, Videos and Presentations. 29 million people in the EU suffer from liver disease. Liver disease includes a range of diseases and symptoms, most of which have a significant inflammatory. Learn More About the Project.

WHAT DOES ORBSENTHERAPEUTICS.COM LOOK LIKE?

Desktop Screenshot of orbsentherapeutics.com Mobile Screenshot of orbsentherapeutics.com Tablet Screenshot of orbsentherapeutics.com

CONTACTS

VIVIENNE MOLLOY

1 Woodmount, Ballinderreen

KIlcolgan, none

IE

Namesco Limited

Domain Administrator

Acton House, Perdiswell Park

Worcester, WR3 7GD

GB

Namesco Limited

Namesco Limited

Acton House, Perdiswell Park

Worcester, WR3 7GD

GB

ORBSENTHERAPEUTICS.COM HOST

We diagnosed that the main page on orbsentherapeutics.com took nine hundred and fifty-three milliseconds to download. We identified a SSL certificate, so therefore our web crawlers consider this site secure.
Load time
0.953 secs
SSL
SECURE
Internet Protocol
104.18.51.107

NAME SERVERS

ns0.reg365.net
ns1.reg365.net
ns2.reg365.net

BROWSER ICON

SERVER OS

I observed that this domain is weilding the cloudflare operating system.

PAGE TITLE

Home - Orbsen Therapeutics

DESCRIPTION

In the News Product Pipeline We are working on the development of an extensive range of therapies based on our proprietary technologies. The targets for these therapies include Diabetic Foot Ulcers Acute Respiratory Distress Syndrome - ARDS Diabetic Kidney Disease - DKD

CONTENT

This domain had the following on the homepage, "Dr Larry Couture Named CEO Of Orbsen Therapeutics." We observed that the web page said " Orbsen Therapeutics Receives Approval from European Regulators for Clinical Trial of Breakthrough Cell Therapy for Diabetic Kidney Disease." It also stated " Dr Jack Kavanaugh Named Chairman of Orbsen. Orbsen Awarded 6 Million Euros to Test Cell Therapy for Diabetic Kidney Disease. We are working on the development of an extensive range of therapies based on our proprietary technologies. The targets for these therapies include. Diabetic Kidney Disease DKD."

SEEK OTHER WEB SITES

orbservator blog

Click pentru a vedea mai multe. Mai jos am pus cateva felicitari noi cu 8 martie care pot fi oferite oricui. Se apropie 1 decembrie 2011, ziua Romaniei, ziua romanilor. ro este o campanie initiata de Protv, Sport. ro, Gandul, Prosport, Ziarul Finaciar, Stirile Protv si Protv International pentru a trezi sentimentul de patriotism. Fa reclama Romaniei cu mana noastra. Participa la cea mai mare campanie de imagine pentru Romania. 1 DJ Antoine, T.

orbsf Silence DeviantArt

This is the place where you can personalize your profile! By moving, adding and personalizing widgets. You can drag and drop to rearrange. You can edit widgets to customize them. The bottom has widgets you can add! Some widgets you can only access when you get Core Membership.

Welcome to O.R.B.S.

We specialize in hyper-intelligent, virtual racing. Racers compete in intense downhill races for spectators worldwide to view. Since 2019, alongside international tech-giant GyroTech, O. Due to its size, the rhinoceros is not known for its speed.

Orbs in Photos - Orbs of Light - What are Orbs

This image is a typical white sometimes translucent type orb I would often see floating around my house often shooting off in high speed motions. Other times they will float around and move slowly and typically linger around to just let me know that they were here. Here we have your typical orb. Less detailed than the one above. These appear to be one dimensional orbs in photos. This one does appear to have some facial features to it as well.